On May 17, the Philadelphia Phillies are taking on more than the Cincinnati Reds: they’ve joined with Jefferson’s Department of Neurological Surgery and the National Brain Tumor Society to build awareness and support patients diagnosed with brain tumors.
Each year nearly 70,000 people are diagnosed with brain tumors in the U.S. with about 24,620 cases of malignant tumors and 45,100 benign tumors, according to federal estimates.
Saturday is Brain Tumor Awareness Night at Citizens Bank Park. You can support this important cause by going to http://philadelphia.phillies.mlb.com, clicking on the green “T” and using the password “BTAN.” Proceeds from tickets sold through this offer will benefit awareness and patient support programs for Jefferson and the National Brain Tumor Society.
Jefferson is a national leader in research and treatment of both brain cancer and noncancerous tumors. Jefferson Hospital for Neuroscience cares for more than 1,100 patients with brain tumors each year. Our team of neurosurgeons, neurologists, radiation oncologists and other health professionals is among the nation’s most experienced and busiest.
“Because of the depth of our expertise and the large number of brain tumor patients we treat, Jefferson has long been a leader in developing innovative new treatments for our patients,” explains neurosurgeon David W. Andrews, MD, director of the Division of Neuro-Oncologic Neurosurgery and Stereotactic Radiosurgery.
The Jefferson Brain Tumor Center of the Kimmel Cancer Center provides a multidisciplinary approach to treating brain tumors, giving patients access to care all in one place and during one visit.